These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 21512274)
61. Engraftment of human T, B and NK cells in CB.17 SCID/beige mice by transfer of human spleen cells. Yacoub-Youssef H; Marcheix B; Calise D; Thiers JC; Therville N; Benoist H; Blaes N; Ségui B; Dambrin C; Thomsen M Transpl Immunol; 2005 Dec; 15(2):157-64. PubMed ID: 16412960 [TBL] [Abstract][Full Text] [Related]
62. Engraftment potential of adult spleen cells in vitro and in vivo. Dor FJ; Cooper DK Transpl Immunol; 2006 Aug; 16(2):131. PubMed ID: 16860717 [No Abstract] [Full Text] [Related]
63. The NOD/Shi-scid/IL-2Rγ(null) mice xenograft model recapitulates anaplastic large cell lymphoma dissemination to the bladder. Daifu T; Umeda K; Kouzuki K; Hamabata T; Noudomi S; Saida S; Kato I; Hiramatsu H; Watanabe K; Terada N; Imamura M; Ogawa O; Heike T; Adachi S Leuk Lymphoma; 2015 May; 56(5):1542-3. PubMed ID: 25248877 [No Abstract] [Full Text] [Related]
64. Comparison of biological features between severely immuno-deficient NOD/Shi-scid Il2rg Nagatani M; Kodera T; Suzuki D; Igura S; Fukunaga Y; Kanemitsu H; Nakamura D; Mochizuki M; Kemi M; Tamura K; Kasahara K Exp Anim; 2019 Nov; 68(4):471-482. PubMed ID: 31118345 [TBL] [Abstract][Full Text] [Related]
66. Improved B cell development in humanized NOD Jangalwe S; Shultz LD; Mathew A; Brehm MA Immun Inflamm Dis; 2016 Dec; 4(4):427-440. PubMed ID: 27980777 [TBL] [Abstract][Full Text] [Related]
67. Human T cell development in the liver of humanized NOD/SCID/IL-2Rγ(null)(NSG) mice generated by intrahepatic injection of CD34(+) human (h) cord blood (CB) cells. Choi B; Chun E; Kim M; Kim SY; Kim ST; Yoon K; Lee KY; Kim SJ Clin Immunol; 2011 Jun; 139(3):321-35. PubMed ID: 21429805 [TBL] [Abstract][Full Text] [Related]
68. Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis. Zhang L; Meissner E; Chen J; Su L Sci China Life Sci; 2010 Feb; 53(2):195-203. PubMed ID: 20596827 [TBL] [Abstract][Full Text] [Related]
69. Characterization of the NOD/scid-[Tg]DR1 mouse expressing HLA-DRB1*01 transgene: a model of SCID-hu mouse for vaccine development. Camacho RE; Wnek R; Fischer P; Shah K; Zaller DM; Woods A; La Monica N; Aurisicchio L; Fitzgerald-Bocarsly P; Koo GC Exp Hematol; 2007 Aug; 35(8):1219-30. PubMed ID: 17662890 [TBL] [Abstract][Full Text] [Related]
70. An in vivo model of priming of antigen-specific human CTL by Mo-DC in NOD/Shi-scid IL2rgamma(null) (NOG) mice. Inoue M; Senju S; Hirata S; Irie A; Baba H; Nishimura Y Immunol Lett; 2009 Sep; 126(1-2):67-72. PubMed ID: 19682495 [TBL] [Abstract][Full Text] [Related]
71. Molecular cloning of the cDNA coding sequence of IL-2 receptor-gamma (gammac) from human and murine forebrain: expression in the hippocampus in situ and by brain cells in vitro. Petitto JM; Huang Z; Raizada MK; Rinker CM; McCarthy DB Brain Res Mol Brain Res; 1998 Jan; 53(1-2):152-62. PubMed ID: 9473647 [TBL] [Abstract][Full Text] [Related]
72. Human hematopoietic stem/progenitor cells generate CD5+ B lymphoid cells in NOD/SCID mice. Novelli EM; Ramírez M; Leung W; Civin CI Stem Cells; 1999; 17(5):242-52. PubMed ID: 10527459 [TBL] [Abstract][Full Text] [Related]
73. Identification of a key molecular regulator of liver metastasis in human pancreatic carcinoma using a novel quantitative model of metastasis in NOD/SCID/gammacnull (NOG) mice. Suemizu H; Monnai M; Ohnishi Y; Ito M; Tamaoki N; Nakamura M Int J Oncol; 2007 Oct; 31(4):741-51. PubMed ID: 17786304 [TBL] [Abstract][Full Text] [Related]
74. Establishment of a new model of human multiple myeloma using NOD/SCID/gammac(null) (NOG) mice. Miyakawa Y; Ohnishi Y; Tomisawa M; Monnai M; Kohmura K; Ueyama Y; Ito M; Ikeda Y; Kizaki M; Nakamura M Biochem Biophys Res Commun; 2004 Jan; 313(2):258-62. PubMed ID: 14684154 [TBL] [Abstract][Full Text] [Related]
75. Effects of human interleukin-18 and interleukin-12 treatment on human lymphocyte engraftment in NOD-scid mouse. Senpuku H; Asano T; Matin K; Salam MA; Tsuha Y; Horibata S; Shimazu Y; Soeno Y; Aoba T; Sata T; Hanada N; Honda M Immunology; 2002 Oct; 107(2):232-42. PubMed ID: 12383203 [TBL] [Abstract][Full Text] [Related]
76. Establishing EGFP congenic mice in a NOD/Shi-scid IL2Rg(null) (NOG) genetic background using a marker-assisted selection protocol (MASP). Suemizu H; Yagihashi C; Mizushima T; Ogura T; Etoh T; Kawai K; Ito M Exp Anim; 2008 Oct; 57(5):471-7. PubMed ID: 18946184 [TBL] [Abstract][Full Text] [Related]
77. Efficient production of immunodeficient non-obese diabetic/Shi-scid Goto M; Takeo T; Takahashi R; Nakagata N Lab Anim; 2021 Feb; 55(1):13-20. PubMed ID: 32507045 [TBL] [Abstract][Full Text] [Related]
78. Improved engraftment of human peripheral blood mononuclear cells in NOG MHC double knockout mice generated using CRISPR/Cas9. Ka Y; Katano I; Nishinaka E; Welcker J; Mochizuki M; Kawai K; Goto M; Tomiyama K; Ogura T; Yamamoto T; Ito M; Ito R; Takahashi R Immunol Lett; 2021 Jan; 229():55-61. PubMed ID: 33253759 [TBL] [Abstract][Full Text] [Related]
79. [Establishment of human acute B-lymphoblastic leukemia NOD/SCID/IL2 receptor γ chain(null) neonatal mouse xenotransplant model]. Kong Y; Liu YR; Liu KY; Huang XJ; Ishikawa F; Harada M Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):762-8. PubMed ID: 22739198 [TBL] [Abstract][Full Text] [Related]